Structural modifications and kinetic effects of KRAS interactions with HRAS and NRAS: an in silico comparative analysis of KRAS mutantsFRONTIERS IN MOLECULAR BIOSCIENCESIF42024-08-092OAAI
Carbamazepine mediated SMARCA4 inhibition as a therapeutic target for KRAS-mutated CRCCANCER RESEARCHIF16.62024-03-220PRE
Molecular dynamic simulations of RAS family protein interactions: Mutant KRAS binding with wildtype HRAS and NRASCANCER RESEARCHIF16.62024-03-220PRE
Targeting intermediates of the PRMT5/BRG1 axis as a combination therapyCANCER RESEARCHIF16.62024-03-220PRE
Impact of carbamazepine on SMARCA4 (BRG1) expression in colorectal cancer: modulation by KRAS mutation statusINVESTIGATIONAL NEW DRUGSIF2.72024-03-063OAAI